These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38956834)

  • 1. Where will Medicines that Serve the Global South and Economically Disadvantaged People Come From?
    Hu M
    Curr Drug Metab; 2024; 25(1):1. PubMed ID: 38956834
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Intern Med J; 2015 Feb; 45(2):123-7. PubMed ID: 25650533
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrology in the developing world. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V
    Nat Rev Nephrol; 2015 Mar; 11(3):128-9. PubMed ID: 25629510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The world we want: focus on the most disadvantaged.
    Thomsen S; Biao X; Kusnanto H; Mavalankar D; Målqvist M; Ng N; Diwan V
    Glob Health Action; 2013 Apr; 6():1-3. PubMed ID: 23578569
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):221-6. PubMed ID: 25758866
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Nephron Clin Pract; 2014; 128(3-4):292-6. PubMed ID: 25614182
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical research with economically disadvantaged populations.
    Denny CC; Grady C
    J Med Ethics; 2007 Jul; 33(7):382-5. PubMed ID: 17601862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on the United Nations Millennium Development Goals.
    Campbell DA
    J Obstet Gynecol Neonatal Nurs; 2017; 46(3):e48-e55. PubMed ID: 28285005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CKD in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Am J Nephrol; 2015; 41(2):116-20. PubMed ID: 25766137
    [No Abstract]   [Full Text] [Related]  

  • 10. Health equity in Hospital at Home: Outcomes for economically disadvantaged and non-disadvantaged patients.
    Siu AL; Zhao D; Bollens-Lund E; Lubetsky S; Schiller G; Saenger P; Ornstein KA; Federman AD; DeCherrie LV; Leff B
    J Am Geriatr Soc; 2022 Jul; 70(7):2153-2156. PubMed ID: 35363372
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Nephrology (Carlton); 2015 Mar; 20(3):113-6. PubMed ID: 25712555
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 Laid Bare How Systemic Inequities Remain.
    Torbay R
    Health Aff (Millwood); 2020 Sep; 39(9):1656. PubMed ID: 32897785
    [No Abstract]   [Full Text] [Related]  

  • 13. The Health Impact Fund: incentives for improving access to medicines.
    Banerjee A; Hollis A; Pogge T
    Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccines and medicines for the world's poorest. Public-private partnerships seem to be essential.
    Smith R
    BMJ; 2000 Apr; 320(7240):952-3. PubMed ID: 10753128
    [No Abstract]   [Full Text] [Related]  

  • 15. The invisible vulnerable: the economically and educationally disadvantaged subjects of clinical research.
    Stone TH
    J Law Med Ethics; 2003; 31(1):149-53. PubMed ID: 12762108
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic kidney disease in disadvantaged populations.
    Garcia-Garcia G; Jha V;
    Transplantation; 2015 Jan; 99(1):13-6. PubMed ID: 25525919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Insecurity and Social Protection: Pathways, Gaps, and Their Implications on Health Outcomes and Poverty.
    Gama E
    Int J Health Policy Manag; 2015 Nov; 5(3):183-7. PubMed ID: 26927589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor nations push for right to produce cheap medicines.
    Goodman S
    Nature; 2001 Jun; 411(6841):982. PubMed ID: 11429562
    [No Abstract]   [Full Text] [Related]  

  • 19. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
    Burci GL; Gostin LO
    JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.